Byetta Injury Lawyer

Several studies have linked diabetes drugs to pancreatic cancer and pancreatitis. If you suspect you or a loved one’s pancreatic cancer or pancreatitis is from diabetes drug usage, call our lawyers today for a free legal consultation. We will help you explore your legal options.

 

Byetta® Linked to Pancreatitis and Pancreatic Cancer

Byetta is a diabetes drug that may increase the possibility of pancreatitis and pancreatic cancer. The FDA began issuing healthcare provider alerts in 2007 that Byetta may present an increased risk of pancreatitis in Byetta users. In 2011, University of California researchers found that Byetta users had three times the risk of pancreatic cancer.

 

How Byetta May Cause Pancreatitis and Pancreatic Cancer

Byetta is also known as exenatide and helps the body control blood sugar levels. Byetta affects the GLP-1 metabolic pathway, which is in the pancreas. GLP-1 drugs can increase chronic inflammation, encourage cell proliferation, reduce normal cell degradation, change cell responses, inhibit the immune systems ability to fight cancer, reduce normal cell death, which make cancer more likely.

 

Byetta Lawsuits Already Filed

At this point there have been no jury awards for Byetta causing pancreatitis or pancreatic cancer. However, Byetta lawsuits have been filed in California, which is the MDL for Byetta litigation. An MDL is a multidistrict litigation.

 

Legal Help for Victims of Byetta

Woods & Woods has partnered with law firms around the country to help victims of medicine injuries. Woods & Woods was founded in 1985 to help injured people. We offer free legal consultations on Byetta injuries. If you want justice for yourself or a loved one simply fill out the contact form or call toll-free 1-866-232-5777.

 

Sources

Food and Drug Administration
U.S. National Library of Medicine

Never stop taking any medication without first consulting your doctor. Byetta® is a registered trademark of Amylin Pharmaceuticals Inc. and is used here only for the purpose of identifying the product in question. This law firm is not associated with, sponsored by, or affiliated with the U.S. Food and Drug Administration, University of California, or Amylin Pharmaceuticals Inc. Cases may be referred to other attorneys.